Searchable abstracts of presentations at key conferences in endocrinology

ea0025pl2biog | Society for Endocrinology Hoffenberg International Medal Lecture | SFEBES2011

Society for Endocrinology Hoffenberg International Medal Lecture

Fuller Peter J

Peter J Fuller, Prince Henry’s Institute, Clayton, Victoria, Australia. AbstractProfessor Fuller is an NHMRC Senior Principal Research Fellow at Prince Henry's Institute of Medical Research in Melbourne where is the Associate Director and Head of the Steroid Receptor Biology Group. He is also Director of the Endocrinology Unit at the Monash Medical Centre/Southern Health and an Adjunct Professor in Medicine and ...

ea0038pl7biog | Clinical Endocrinology Trust Visiting Professor Lecture | SFEBES2015

Clinical Endocrinology Trust Visiting Professor Lecture

Auchus Richard J

Dr Richard J Auchus is Professor of Pharmacology and Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan and Director of the Diabetes, Endocrinology, & Metabolism Fellowship Program at Michigan. He did postdoctoral work and training at the University of California, San Francisco prior to joining the faculty at UT Southwestern in Dallas. He served as Acting Chi...

ea0042il4 | Androgen Receptor | Androgens2016

Modulation of androgen receptor signaling in prostate cancer cells by SUMOylation and NFκB pathways

Palvimo Jorma J.

Transcriptional activity of androgen receptor (AR) is governed by androgenic ligands and (thought to be) fine-tuned by post-translational modifications, such as SUMOylation. We have utilized genome-wide tools to study in an unbiased fashion the role of SUMOylation in the regulation of AR-directed gene programs in prostate cancer cells. Our results show that the SUMOylation does not simply repress the AR activity, but the modification modulates the receptor activity in a target...

ea0082wa11 | Workshop A: Disorders of the hypothalamus and pituitary | SFEEU2022

A case of lymphocytic hypophysitis presenting with diabetes insipidus

Gaur Smriti , Aboul Hossn Tamara , Morris Damian

Introduction: Lymphocytic hypophysitis(LH) is a rare autoimmune endocrinopathy that causes pituitary gland inflammation, resulting in hypopituitarism. Headache is the most common presenting symptom; however, diabetes insipidus (DI) may be the first feature in some patients. Here we report one such case. Case: a 36-year-old female was referred to the Endocrine clinic with sudden onset of polydipsia, polyuria and nocturia. She also reported amenorrhoea but...

ea0020p150 | Thyroid | ECE2009

Fever in the debute of the diffuse toxic goiter

Kamynina Tamara , Gubkina Valeria , Dreval Alexander

Aim: To pay attention to the so rare symptom of diffuse toxic goiter (DTG) as fever.Materials and methods: We report about 5 patients (all females, aged 18–38, mean – 31). Before, all patients were examined for fever of unknown origin of long duration. After the others reasons of the febrile body temperature were excluded, DTG was diagnosed. DTG was confirmed by the results of the clinical, hormonal and immunological investigations (T- and B-ce...

ea0010oc3 | Reproduction, neuroendocrinology and diabetes | SFE2005

Endogenous opioid inhibition of hypothalamo-pituitary-adrenal (HPA) axis responses to centrally administered neuropeptide y (NPY) during late pregnancy

Bales J , Searle A , Brunton|J##Russell P , #Brunton|# #Brunton|#

NPY acts centrally to stimulate appetite and the HPA axis. During late pregnancy enhanced inhibition of parvocellular paraventricular nucleus (pPVN) corticotrophin releasing hormone (CRH)/ arginine vasopressin (AVP) neurones reduces HPA-axis stress responses1,2. We investigated activation of hypothalamic neurones regulating HPA responses to NPY, and a role for endogenous opioids in HPA hyporesponsiveness in late pregnancy.Pregnant (d21) and vi...

ea0006oc20 | Growth and Development | SFE2003

THE EFFECT OF MATERNAL NUTRITION DURING THE FIRST OR SECOND HALF OF GESTATION ON GLUCOSE TOLERANCE OF THE SOW

Corson A , Litten J , Perkins K , Laws J , Clarke L

In humans, pregnancy is considered a diabetogenic event1. A similar situation occurs in sows1. The amount of fat in the sows' diet is inversely correlated to glucose clearance time, thus modifying glucose tolerance2. The aim was to investigate the influence of altered maternal diet during gestation (term = 115days) on the glucose tolerance of the sow. Thirty-four pregnant sows were randomly allocated to 4 isocaloric diets for either the first (G1) or second (G2) 60 days of ges...

ea0006dp17 | Diabetes, metabolism and cardiovascular | SFE2003

THE EFFECT OF MATERNAL NUTRITION DURING THE FIRST OR SECOND HALF OF GESTATION ON GLUCOSE TOLERANCE OF THE SOW

Corson A , Litten J , Perkins K , Laws J , Clarke L

In humans, pregnancy is considered a diabetogenic event1. A similar situation occurs in sows1. The amount of fat in the sows' diet is inversely correlated to glucose clearance time, thus modifying glucose tolerance2. The aim was to investigate the influence of altered maternal diet during gestation (term = 115days) on the glucose tolerance of the sow. Thirty-four pregnant sows were randomly allocated to 4 isocaloric diets for either the first (G1) or second (G2) 60 days of ges...

ea0002oc2 | Signalling from Cell Surface to Nucleus | SFE2001

LPS ACTS VIA IL-6 TO MODULATE THE EXPRESSION AND PHOSPHORYLATION OF ANNEXIN 1 IN CELL LINES DERIVED FROM THE MICROGLIA OF THE NEUROENDOCRINE SYSTEM

Solito E , Mulla A , Buckingham J

Annexin 1 (ANXA1, lipocortin 1), a Ca2+ and phospholipid binding protein, is a strong candidate mediator of the interplay between the immune and neuroendocrine systems. Within the neuroendocrine system ANXA1 is expressed in abundance by the non-secretory pituitary folliculo-stellate (FS) cells (1), which show characteristics of resident microglia. We have previously reported that IL-6 up-regulates ANXA1 expression in the liver in vivo and in A549 cells (lung epithelial...